Structure-activity relationships of histamine H2 receptor ligands

被引：31
|
作者：
Dove, S
Elz, S
Seifert, R
Buschauer, A [1 ]
机构：
[1] Univ Regensburg, Inst Pharm, D-93040 Regensburg, Germany
[2] Univ Kansas, Dept Pharmacol & Toxicol, Lawrence, KS 66045 USA
来源：
MINI-REVIEWS IN MEDICINAL CHEMISTRY | 2004年 / 4卷 / 09期
关键词：
H-2 receptor agonists; H-2 receptor antagonists; impromidine analogues; arpromidine; molecular modelling; structure-activity relationships; QSAR; site-directed mutagenesis;
D O I：
10.2174/1389557043403242
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Recent research on histamine H-2 receptor agonists was focused on quantitative structure-activity relationships and receptor models explaining the activity of imidazolylpropylguanidines. Their selectivity for guinea pig vs. human isoforms was investigated using H-2 receptor-G(salpha) fusion proteins and attributed to amino acid differences in transmembrane domains 1 and 7. New antagonists result from approaches to improve pharmacokinetic properties and to design hybrid drugs which additionally have gastroprotective or anti H. pylori activity.
引用
收藏
页码：941 / 954
页数：14
相关论文
共 50 条
  • [31] Quantitative analysis of structure-activity relationships of tetrahydro-2H-isoindole cyclooxygenase-2 inhibitors
    Khayrullina, V. R.
    Gerchikov, A. Ya.
    Lagunin, A. A.
    Zarudii, F. S.
    BIOCHEMISTRY-MOSCOW, 2015, 80 (01) : 74 - 86
  • [32] Structure-activity relationships for antiplasmodial activity among aminoquinolines
    Qi, YH
    Xu, L
    Liu, ZY
    CHEMICAL JOURNAL OF CHINESE UNIVERSITIES-CHINESE, 2000, 21 (02): : 219 - 221
  • [33] STRUCTURE-ACTIVITY-RELATIONSHIPS IN ANTAGONIST AND INVERSE AGONIST LIGANDS FOR THE BENZODIAZEPINE RECEPTOR
    CODDING, PW
    ROSZAK, AW
    SRKARADZINSKA, MB
    COOK, JM
    HAGEN, TJ
    ALLEN, MS
    CANADIAN JOURNAL OF CHEMISTRY-REVUE CANADIENNE DE CHIMIE, 1995, 73 (04): : 499 - 512
  • [34] Histamine H4 Receptor Ligands: Future Applications and State of Art
    Correa, Michelle Fidelis
    dos Santos Fernandes, Joao Paulo
    CHEMICAL BIOLOGY & DRUG DESIGN, 2015, 85 (04) : 461 - 480
  • [35] Antimalarial activity and structure-activity relationships of protoberberine alkaloids
    Iwasa, K
    Kim, HS
    Wataya, Y
    Lee, DU
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1998, 33 (01) : 65 - 69
  • [36] Structure-activity relationships for selected fragrance allergens
    Patlewicz, GY
    Wright, ZM
    Basketter, DA
    Pease, CK
    Lepoittevin, JP
    Arnau, EG
    CONTACT DERMATITIS, 2002, 47 (04) : 219 - 226
  • [37] Structure-activity relationships of KATP channel openers
    Mannhold, R
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2006, 6 (10) : 1031 - 1047
  • [38] Application of neural networks in structure-activity relationships
    Kövesdi, I
    Dominguez-Rodriguez, MF
    Orfi, L
    Náray-Szabó, G
    Varro, A
    Papp, JG
    Mátyus, P
    MEDICINAL RESEARCH REVIEWS, 1999, 19 (03) : 249 - 269
  • [39] New antiepileptic agents: structure-activity relationships
    Banerjee, Pooja S.
    Sharma, P. K.
    MEDICINAL CHEMISTRY RESEARCH, 2012, 21 (07) : 1491 - 1508
  • [40] Feature selection in quantitative structure-activity relationships
    Walters, WP
    Goldman, BB
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2005, 8 (03) : 329 - 333
12345